References
- CDC Antibiotic Resistance. Antibiotic Resistance Threats in the United States. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. December 2019. Last accessed 27 February 2021.
- Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A. K. M.; Wertheim, H. F. L.; Sumpradit, N.; Vlieghe, E.; Hara, G. L.; Gould, I. M.; Goossens, H.; et al. Antibiotic Resistance-the Need for Global Solutions. Lancet Infect. Dis. 2013, 13, 1057–1098. DOI:https://doi.org/10.1016/S1473-3099(13)70318-9.
- Annunziato, G. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review. IJMS 2019, 20, 5844. DOI: https://doi.org/10.3390/ijms20235844.
- Duval, R. E.; Grare, M.; Demoré, B. Fight against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria. Molecules 2019, 24, 3152. DOI: https://doi.org/10.3390/molecules24173152.
- Xu, W. C.; Silverman, M. H.; Yu, X. Y.; Wright, G.; Brown, N. Discovery and Development of DNA Polymerase IIIC Inhibitors to Treat Gram-Positive Infections. Bioorg. Med. Chem. 2019, 27, 3209–3217. DOI: https://doi.org/10.1016/j.bmc.2019.06.017.
- Sanad, S. M. H.; Mekky, A. E. M. Synthesis and Antibacterial Evaluation of New Pyrido[3′,2′:4,5]Thieno[3,2-d]Pyrimidin-4 (3H)-One Hybrids Linked to Different Heteroarene Units. Mendeleev. Commun. 2021, 31, 862–864. DOI: https://doi.org/10.1016/j.mencom.2021.11.031.
- Sanad, S. M. H.; Mekky, A. E. M. Synthesis, Cytotoxicity and in Vitro Antibacterial Screening of Novel Hydrazones Bearing Thienopyridine Moiety as Potent COX-2 Inhibitors. J. Iran Chem. SOC 2020, 17, 3299–3315. DOI: https://doi.org/10.1007/s13738-020-01987-y.
- Mekky, A. E. M.; Sanad, S. M. H.; Said, A. Y.; Elneairy, M. A. A. Synthesis, Cytotoxicity, in-Vitro Antibacterial Screening and in-Silico Study of Novel Thieno[2,3-b]Pyridines as Potential Pim-1 Inhibitors. Synth. Commun. 2020, 50, 2376–2389. DOI: https://doi.org/10.1080/00397911.2020.1778033.
- Sanad, S. M. H.; Ahmed, A. A. M.; Mekky, A. E. M. Efficient Synthesis and Molecular Docking of Novel Antibacterial Pyrimidines and Their Related Fused Heterocyclic Derivatives. J. Heterocyclic Chem. 2020, 57, 590–605. DOI: https://doi.org/10.1002/jhet.3789.
- Guimarães, C. R. W.; Boger, D. L.; Jorgensen, W. L. Elucidation of Fatty Acid Amide Hydrolase Inhibition by Potent α-Ketoheterocycle Derivatives from Monte Carlo Simulations. J. Am. Chem. Soc. 2005, 127, 17377–17384. DOI: https://doi.org/10.1021/ja055438j.
- Bhasin, G.; Srivastava, R.; Singh, R. Oxadiazoles: Moiety to Synthesis and Utilize. J. Iran Chem. SOC 2022, 19, 665–677. DOI: https://doi.org/10.1007/s13738-021-02335-4.
- Glomb, T.; Świątek, P. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives. IJMS 2021, 22, 6979. DOI: https://doi.org/10.3390/ijms22136979.
- Mermer, A.; Faiz, O.; Demirbas, A.; Demirbas, N.; Alagumuthu, M.; Arumugam, S. Piperazine-Azole-Fluoroquinolone Hybrids: Conventional and Microwave Irradiated Synthesis, Biological Activity Screening and Molecular Docking Studies. Bioorg. Chem. 2019, 85, 308–318. DOI: https://doi.org/10.1016/j.bioorg.2019.01.009.
- Guo, Y.; Xu, T.; Bao, C.; Liu, Z.; Fan, J.; Yang, R.; Qin, S. Design and Synthesis of New Norfloxacin-1,3,4-Oxadiazole Hybrids as Antibacterial Agents against Methicillin-Resistant Staphylococcus aureus (MRSA). Eur. J. Pharm. Sci. 2019, 136, 104966. DOI: https://doi.org/10.1016/j.ejps.2019.104966.
- Siwach, A.; Verma, P. K. Therapeutic Potential of Oxadiazole or Furadiazole Containing Compounds. BMC Chem. 2020, 14, 70. DOI: https://doi.org/10.1186/s13065-020-00721-2.
- Zheng, Z.; Liu, Q.; Kim, W.; Tharmalingam, N.; Fuchs, B. B.; Mylonakis, E. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives against Planktonic Cells and Biofilm of Staphylococcus aureus. Future Med. Chem. 2018, 10, 283–296. DOI: https://doi.org/10.4155/fmc-2017-0159.
- Nazar, S.; Siddiqui, N.; Alam, O. Recent Progress of 1,3,4‐Oxadiazoles as Anticonvulsants: Future Horizons. Arch. Pharm. 2020, 353, e1900342. DOI: https://doi.org/10.1002/ardp.201900342.
- Ahsan, M. J.; Bhandari, L.; Makkar, S.; Singh, R.; Hassan, M. Z.; Geesi, M. H.; Bakht, M. A.; Jadav, S. S.; Balaraju, T.; Riadi, Y.; et al. Synthesis, Antiproliferative, and Antioxidant Activities of Substituted N-[(1,3,4-Oxadiazol-2-yl) Methyl] Benzamines. LDDD 2020, 17, 145–154. DOI: https://doi.org/10.2174/1570180816666181113110033.
- Jawed Ahsan, M.; Meena, R.; Dubey, S.; Khan, V.; Manda, S.; Singh Jadav, S.; Sharma, P.; Geesi, M. H.; Hassan, M. Z.; Afroz Bakht, M.; et al. Synthesis and Biological Potentials of Some New 1,3,4-Oxadiazole Analogues. Med. Chem. Res. 2018, 27, 864–883. DOI: https://doi.org/10.1007/s00044-017-2109-1.
- Ahsan, M. J.; Yadav, R. P.; Saini, S.; Hassan, M.; Bakht, M. A.; Jadav, S. S.; Al-Tamimi, A.; Geesi, M. H.; Ansari, M. Y.; Khalilullah, H.; Riadi, Y. Synthesis, Cytotoxic Evaluation, and Molecular Docking Studies of New Oxadiazole Analogues. Lett. Org. Chem. 2018, 15, 49–56. DOI: https://doi.org/10.2174/1570178614666170704103315.
- Ahsan, M. J.; Samy, J. G.; Jain, C. B.; Dutt, K. R.; Khalilullah, H.; Nomani, M. S. Discovery of Novel Antitubercular 1,5-Dimethyl-2-Phenyl-4-([5-(Arylamino)-1,3,4-Oxadiazol-2-yl]Methylamino)-1,2-Dihydro-3H-Pyrazol-3-One Analogues. Bioorg. Med. Chem. Lett. 2012, 22, 969–972. DOI: https://doi.org/10.1016/j.bmcl.2011.12.014.
- Gan, X.; Hu, D.; Li, P.; Wu, J.; Chen, X.; Xue, W.; Song, B. Design, Synthesis, Antiviral Activity and Three‐Dimensional Quantitative Structure-Activity Relationship Study of Novel 1,4‐Pentadien‐3‐One Derivatives Containing the 1,3,4‐Oxadiazole Moiety. Pest. Manag. Sci. 2016, 72, 534–543. DOI: https://doi.org/10.1002/ps.4018.
- Rathore, A.; Sudhakar, R.; Ahsan, M. J.; Ali, A.; Subbarao, N.; Jadav, S. S.; Umar, S.; Yar, M. S. In Vivo anti-Inflammatory Activity and Docking Study of Newly Synthesized Benzimidazole Derivatives Bearing Oxadiazole and Morpholine Rings. Bioorg. Chem. 2017, 70, 107–117. DOI: https://doi.org/10.1016/j.bioorg.2016.11.014.
- Qamar, S.; Hussain, K.; Bukhar, N. I.; Siddique, S. Z.; Abbas, M. A.; Parveen, S.; Latif, A.; Qamar, A.; Ali, E.; Shehzadi, N.; et al. Evaluating the Antidiabetic and Antioxidant Properties of 5-Benzyl-1,3,4-Oxadiazole-2-Thiol. Trop. J. Pharm. Res. 2021, 18, 1095–1100. DOI: https://doi.org/10.4314/tjpr.v18i5.26.
- Paruch, K.; Popiołek, Ł.; Wujec, M. Antimicrobial and Antiprotozoal Activity of 3-Acetyl-2,5-Disubstituted-1,3,4-Oxadiazolines: A Review. Med. Chem. Res. 2020, 29, 1–16. DOI: https://doi.org/10.1007/s00044-019-02463-w.
- Sudeesh, K.; Gururaja, R. Facile Synthesis of Some Novel Derivatives of 1,3,4-Oxadiazole Derivatives Associated with Quinolone Moiety as Cytotoxic and Antibacterial Agents. Org. Chem. Curr. Res. 2017, 6, 2–5. DOI: https://doi.org/10.4172/2161-0401.1000183.
- Alburquerque-González, B.; Bernabé-García, Á.; Bernabé-García, M.; Ruiz-Sanz, J.; López-Calderón, F. F.; Gonnelli, L.; Banci, L.; Peña-García, J.; Luque, I.; Nicolás, F. J.; et al. The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells in Vitro and in Vivo. Cancers 2021, 13, 861. DOI: https://doi.org/10.3390/cancers13040861.
- Ahsan, M. J. 1,3,4-Oxadiazole Containing Compounds as Therapeutic Targets for Cancer Therapy. Mini. Rev. Med. Chem. 2022, 22, 164–197. DOI: https://doi.org/10.2174/1389557521666210226145837.
- Desai, N. C.; Vaghani, H. V.; Jethawa, A. M.; Khedkar, V. M. In Silico Molecular Docking Studies of Oxadiazole and Pyrimidine Bearing Heterocyclic Compounds as Potential Antimicrobial Agents. Arch. Pharm. 2021, 354, 2100134. DOI: https://doi.org/10.1002/ardp.202100134.
- Chauhan, J.; Ravva, M. K.; Sen, S. Harnessing Autoxidation of Aldehydes: In Situ Iodoarene Catalyzed Synthesis of Substituted 1,3,4-Oxadiazole, in the Presence of Molecular Oxygen. Org. Lett. 2019, 21, 6562–6565. DOI: https://doi.org/10.1021/acs.orglett.9b02542.
- Abdildinova, A.; Gong, Y. D. Current Parallel Solid-Phase Synthesis of Drug-like Oxadiazole and Thiadiazole Derivatives for Combinatorial Chemistry. ACS Comb. Sci. 2018, 20, 309–329. DOI: https://doi.org/10.1021/acscombsci.8b00044.
- Wang, L.; Cao, J.; Chen, Q.; He, M. One-Pot Synthesis of 2,5-Diaryl 1,3,4-Oxadiazoles via di-Tert-Butyl Peroxide Promoted N-Acylation of Aryl Tetrazoles with Aldehydes. J. Org. Chem. 2015, 80, 4743–4748. DOI: https://doi.org/10.1021/acs.joc.5b00207.
- Wang, S.; Wang, K.; Kong, X.; Zhang, S.; Jiang, G.; Ji, F. DMF as Methine Source: Copper‐Catalyzed Direct Annulation of Hydrazides to 1,3,4‐Oxadiazoles. Adv. Synth. Catal. 2019, 361, 3986–3990. DOI: https://doi.org/10.1002/adsc.201900395.
- Liu, L.; Feng, S. Ligand-Free Cu(ii)-Mediated Aerobic Oxidations of Aldehyde Hydrazones Leading to N,N′-Diacylhydrazines and 1,3,4-Oxadiazoles. Org. Biomol. Chem. 2017, 15, 2585–2592. DOI: https://doi.org/10.1039/C7OB00042A.
- Erhardt, H.; Mohr, F.; Kirsch, S. F. Synthesis of the 1,3,4‐Oxadiazole Core through Thermolysis of Geminal Diazides. Eur. J. Org. Chem. 2016, 2016, 5629–5632. DOI: https://doi.org/10.1002/ejoc.201601119.
- Sanad, S. M. H.; Abdel Fattah, A. M.; Attaby, F. A.; Elneairy, M. A. A. Pyridine-2(1H)-Thiones: Versatile Precursors for Novel Pyrazolo[3,4-b]Pyridine, Thieno[2,3-b]Pyridines and Their Fused Azines. J. Heterocyclic Chem. 2019, 56, 651–662. DOI: https://doi.org/10.1002/jhet.3444.
- Sanad, S. M. H.; Hawass, M. A. E.; Ahmed, A. A. M.; Elneairy, M. A. A. Facile Synthesis and Characterization of Novel Pyrido[3',2':4,5]Thieno[3,2-d]Pyrimidin-4(3H)-One and Pyrido[2′,3′:3,4]Pyrazolo[1,5-a]Pyrimidine Incorporating 1,3-Diarylpyrazole Moiety. Synth. Commun. 2018, 48, 1847–1856. DOI: https://doi.org/10.1080/00397911.2018.1468911.
- Yadav, A. K.; Yadav, L. D. S. Visible-Light-Promoted Aerobic Oxidative Cyclization to Access 1,3,4-Oxadiazoles from Aldehydes and Acylhydrazides. Tetrahedron Lett. 2014, 55, 2065–2069. DOI: https://doi.org/10.1016/j.tetlet.2014.02.022.
- Zhao, Q.; Ren, L.; Hou, J.; Yu, W.; Chang, J. Annulation Reactions of in-Situ-Generated n-(Het)Aroyldiazenes with Isothiocyanates Leading to 2-Imino-1,3,4-Oxadiazolines. Org. Lett. 2018, 21, 210–213. DOI: https://doi.org/10.1021/acs.orglett.8b03663.
- Zhou, R.; Han, L.; Zhang, H.; Liu, R.; Li, R. A Deoxygenative [4 + 1] Annulation Involving N‐Acyldiazenes for an Efficient Synthesis of 2,2,5‐Trisubstituted 1,3,4‐Oxadiazole Derivatives. Adv. Synth. Catal. 2017, 359, 3977–3982. DOI: https://doi.org/10.1002/adsc.201700935.
- Andersen, T. L.; Caneschi, W.; Ayoub, A.; Lindhardt, A. T.; Couri, M. R. Skrydstrup, T. 1,2,4‐and 1,3,4‐Oxadiazole Synthesis by Palladium‐Catalyzed Carbonylative Assembly of Aryl Bromides with Amidoximes or Hydrazides. Adv. Synth. Catal. 2014, 356, 3074–3082. DOI: https://doi.org/10.1002/adsc.201400487.
- Tongul, B.; Kavakcıoğlu, B.; Tarhan, L. Chloramine T Induced Oxidative Stress and the Response of Antioxidant System in Phanerochaete chrysosporium. Folia Microbiol. 2018, 63, 325–333. DOI: https://doi.org/10.1007/s12223-017-0571-2.
- Martínez, M. A.; Ares, I.; Rodríguez, J. L.; Martínez, M.; Martínez-Larrañaga, M. R.; Anadón, A. Induction of Cytochrome P450-Dependent Mixed Function Oxidase Activities and Peroxisome Proliferation by chloramine-T in Male Rat Liver. Food Chem. Toxicol. 2017, 106, 86–91. DOI: https://doi.org/10.1016/j.fct.2017.05.012.
- Karabal, P. U.; Chouthaiwale, P. V.; Shaikh, T. M.; Suryavanshi, G.; Sudalai, A. NaIO4/LiBr-Mediated Aziridination of Olefins Using chloramine-T. Tetrahedron Lett. 2010, 51, 6460–6462. DOI: https://doi.org/10.1016/j.tetlet.2010.10.005.
- Agrawal, N.; Mishra, P. The Synthetic and Therapeutic Expedition of Isoxazole and Its Analogs. Med. Chem. Res. 2018, 27, 1309–1344. DOI: https://doi.org/10.1007/s00044-018-2152-6.
- Lavanya, G.; Reddy, L. M.; Padmavathi, V.; Padmaja, A. Synthesis and Antimicrobial Activity of (1,4-Phenylene) Bis (Arylsulfonylpyrazoles and Isoxazoles). Eur. J. Med. Chem. 2014, 73, 187–194. DOI: https://doi.org/10.1016/j.ejmech.2013.11.041.
- Padmaja, A.; Rajasekhar, C.; Muralikrishna, A.; Padmavathi, V. Synthesis and Antioxidant Activity of Oxazolyl/Thiazolylsulfonylmethyl Pyrazoles and Isoxazoles. Eur. J. Med. Chem. 2011, 46, 5034–5038. DOI: https://doi.org/10.1016/j.ejmech.2011.08.010.
- Marri, S.; Kakkerla, R.; Krishna, M. P. S. M.; Rajam, M. V. Synthesis and Antimicrobial Evaluation of Isoxazole-Substituted 1,3,4-Oxadiazoles. Heterocycl. Commun. 2018, 24, 285–292. DOI: https://doi.org/10.1515/hc-2018-0137.
- Ningaiah, S.; Bhadraiah, U. K.; Doddaramappa, S. D.; Keshavamurthy, S.; Javarasetty, C. Novel Pyrazole Integrated 1,3,4-Oxadiazoles: Synthesis, Characterization and Antimicrobial Evaluation. Bioorg. Med. Chem. Lett. 2014, 24, 245–248. DOI: https://doi.org/10.1016/j.bmcl.2013.11.029.
- Sanad, S. M. H.; Mekky, A. E. M.; El-Idreesy, T. T. Potential Bacterial Biofilm, MRSA, and DHFR Inhibitors Based on New Morpholine-Linked Chromene-Thiazole Hybrids: One-Pot Synthesis and in Silico Study. J. Mol. Struct. 2022, 1248, 131476. DOI: https://doi.org/10.1016/j.molstruc.2021.131476.
- Ahmed, N. H. S.; Saad, G. R.; Fahmi, A. A.; Abdelfattah, A. M. Synthesis and Mesomorphic Properties of Laterally Fluoro Azo/Ester Based on Four Ring Compounds with a Wide Range Mesophase Thermal Stability. Liq. Cryst. 2022, 49, 666-678. DOI: https://doi.org/10.1080/02678292.2021.2000053.
- Metwally, N. H.; Koraa, T. H.; Sanad, S. M. H. Green One-Pot Synthesis and in Vitro Antibacterial Screening of Pyrano[2,3-c]Pyrazoles, 4H-Chromenes and Pyrazolo[1,5-a]Pyrimidines Using Biocatalyzed Pepsin. Synth. Commun. 2022, 52, 1139–1154. DOI: https://doi.org/10.1080/00397911.2022.2074301.
- Ahmed, A. A. M.; Mekky, A. E. M.; Sanad, S. M. H. New Piperazine-Based Bis(Thieno[2,3-b]Pyridine) and Bis(Pyrazolo[3,4-b]Pyridine) Hybrids Linked to Benzofuran Units: Synthesis and in Vitro Screening of Potential Acetylcholinesterase Inhibitors. Synth. Commun. 2022, 52, 912–925. DOI: https://doi.org/10.1080/00397911.2022.2056853.
- Sanad, S. M. H.; Ahmed, A. A. M.; Mekky, A. E. M. Synthesis, in-Vitro and in-Silico Study of Novel Thiazoles as Potent Antibacterial Agents and MurB Inhibitors. Arch. Pharm. 2020, 353, e1900309. DOI: https://doi.org/10.1002/ardp.201900309.
- Sanad, S. M. H.; Hanna, D. H.; Mekky, A. E. M. Regioselective Synthesis of Novel Antibacterial Pyrazole-Benzofuran Hybrids: 2D NMR Spectroscopy Studies and Molecular Docking. J. Mol. Struct. 2019, 1188, 214–226. DOI: https://doi.org/10.1016/j.molstruc.2019.03.088.
- Sanad, S. M. H.; Mekky, A. E. M. 3-Aminopyrazolo[3,4-b]Pyridine: Effective Precursor for Barium Hydroxide-Mediated Three Components Synthesis of New Mono- and Bis(Pyrimidines) with Potential Cytotoxic Activity. Chem. Biodiversity 2022, 19, e202100500. DOI: https://doi.org/10.1002/cbdv.202100500.
- Fekri, L. Z.; Nateghi‐Sabet, M. Synthesis of New Azo‐Dispersive Dyes with Benzo[d]Imidazole Moiety and New Bis Benzo[d]Imidazoles Using DABCO‐Diacetate as a Green Media. J. Chin. Chem. Soc. 2021, 68, 695–703. DOI: https://doi.org/10.1002/jccs.202000378.
- Ahmed, A. A. M.; Mekky, A. E. M.; Elwahy, A. H.; Sanad, S. M. H. Facile Synthesis and Characterization of Novel Benzo-Fused Macrocyclic Dicarbonitriles and Pyrazolo-Fused Macrocycles Containing Thiazole Subunits. Synth. Commun. 2020, 50, 796–804. DOI: https://doi.org/10.1080/00397911.2019.1689269.
- Benković, T.; Kontrec, D.; Kazazić, S.; Chiş, V.; Miljanić, S.; Galić, N. Diverse Coordination of Aroylhydrazones toward Iron(III) in Solid State and in Solution: spectrometric, Spectroscopic and Computational Study. Mol. Diversity 2020, 24, 1253–1263. DOI: https://doi.org/10.1007/s11030-019-09989-6.
- Hristova-Avakumova, N. G.; Valcheva, E. P.; Anastassova, N. O.; Nikolova-Mladenova, B. I.; Atanasova, L. A.; Angelova, S. E.; Yancheva, D. Y. In Vitro and in Silico Studies of Radical Scavenging Activity of Salicylaldehyde Benzoylhydrazones. J. Mol. Struct. 2021, 1245, 131021. DOI: https://doi.org/10.1016/j.molstruc.2021.131021.
- Behalo, M. S. An Efficient One-Pot Catalyzed Synthesis of 2,5-Disubstituted-1,3,4-Oxadiazoles and Evaluation of Their Antimicrobial Activities. RSC Adv. 2016, 6, 103132–103136. DOI: https://doi.org/10.1039/C6RA22663A.
- Grover, J.; Bhatt, N.; Kumar, V.; Patel, N. K.; Gondaliya, B. J.; Sobhia, M. E.; Bhutani, K. K.; Jachak, S. M. 2,5-Diaryl-1,3,4-Oxadiazoles as Selective COX-2 Inhibitors and anti-Inflammatory Agents. RSC Adv. 2015, 5, 45535–45544. DOI: https://doi.org/10.1039/c5ra01428j.
- Yu, W.; Huang, G.; Zhang, Y.; Liu, H.; Dong, L.; Yu, X.; Li, Y.; Chang, J. I2-Mediated Oxidative C–O Bond Formation for the Synthesis of 1,3,4-Oxadiazoles from Aldehydes and Hydrazides. J. Org. Chem. 2013, 78, 10337–10343. DOI: https://doi.org/10.1021/jo401751h.
- Musad, E. A.; Mohamed, R.; Saeed, B. A.; Vishwanath, B. S.; Rai, K. L. Synthesis and Evaluation of Antioxidant and Antibacterial Activities of New Substituted Bis(1,3,4-Oxadiazoles), 3,5-Bis(Substituted)Pyrazoles and Isoxazoles. Bioorg. Med. Chem. Lett. 2011, 21, 3536–3540. DOI: https://doi.org/10.1016/j.bmcl.2011.04.142.
- Nayak, Y. N.; Gaonkar, S. L. Chloramine-T (N-Chloro-p-Toluenesulfonamide Sodium Salt), a Versatile Reagent in Organic Synthesis and Analytical Chemistry: An up to Date Review. J. Saudi Chem. Soc. 2022, 26, 101416. DOI: https://doi.org/10.1016/j.jscs.2021.101416.
- Cin, G. T.; Verep, G.; Topel, S. D.; Ciger, V. An Efficient Synthesis of Ferrocenyl-Containing 1,3,4-Oxadiazole Derivatives via Oxidative Cyclization Reaction. Chem. Heterocycl. Compd. 2013, 49, 1061–1067. DOI: https://doi.org/10.1007/s10593-013-1344-8.
- Wang, L.; Qin, W.; Tang, X.; Dou, W.; Liu, W. Development and Applications of Fluorescent Indicators for Mg2+ and Zn2+. J. Phys. Chem. A 2011, 115, 1609–1616. DOI: https://doi.org/10.1021/jp110305k.
- Stevens, M.; Howe, C.; Ray, A. M.; Washburn, A.; Chitre, S.; Sivinski, J.; Park, Y.; Hoang, Q. Q.; Chapman, E.; Johnson, S. M. Analogs of Nitrofuran Antibiotics Are Potent GroEL/ES Inhibitor Pro-Drugs. Bioorg. Med. Chem. 2020, 28, 115710. DOI: https://doi.org/10.1016/j.bmc.2020.115710.
- Mihailović, N.; Marković, V.; Matić, I. Z.; Stanisavljević, N. S.; Jovanović, ŽS.; Trifunović, S.; Joksović, L. Synthesis and Antioxidant Activity of 1,3,4-Oxadiazoles and Their Diacylhydrazine Precursors Derived from Phenolic Acids. RSC Adv. 2017, 7, 8550–8560. DOI: https://doi.org/10.1039/C6RA28787E.
- Thorat, P. B.; Bhong, B. Y.; Karade, N. N. 2,4,6-Tris[(4-Dichloroiodo)Phenoxy)]-1,3,5-Triazine as a New Recyclable Hypervalent Iodine(III) Reagent for Chlorination and Oxidation Reactions. Synlett 2013, 24, 2061–2066. DOI: https://doi.org/10.1055/s-0033-1339495.
- Dubey, S. M.; Gogate, P. R. Ultrasound Assisted Synthesis of 4-Benzyloxy-3-Methoxybenzaldehyde by Selective O-Alkylation of Vanillin with Benzyl Chloride in the Presence of Tetrabutylammonium Bromide. Ind. Eng. Chem. Res. 2014, 53, 7979–7985. DOI: https://doi.org/10.1021/ie5004366.
- Sanad, S. M. H.; Mekky, A. E. M. Synthesis, in-Vitro Antibacterial and Anticancer Screening of Novel Nicotinonitrile-Coumarin Hybrids Utilizing Piperazine Citrate. Synth. Commun. 2020, 50, 1468–1485. DOI: https://doi.org/10.1080/00397911.2020.1743318.
- Mekky, A. E. M.; Sanad, S. M. H. Synthesis and Antibacterial Evaluation of Novel Mono- and Bis(2H-Chromen-2-Imine) Hybrids Linked to Heteroarene Units. Mendeleev Commun. 2020, 30, 762–764. DOI: https://doi.org/10.1016/j.mencom.2020.11.024.
- Bala, S.; Kamboj, S.; Kajal, A.; Saini, V.; Prasad, D. N. 1,3,4-Oxadiazole Derivatives: Synthesis, Characterization, Antimicrobial Potential, and Computational Studies. BioMed Res. Int. 2014, 2014, 172791. DOI: https://doi.org/10.1155/2014/172791.
- Bitla, S.; Sagurthi, S. R.; Dhanavath, R.; Puchakayala, M. R.; Birudaraju, S.; Gayatri, A. A.; Bhukya, V. K.; Atcha, K. R. Design and Synthesis of Triazole Conjugated Novel 2,5-Diaryl Substituted 1,3,4-Oxadiazoles as Potential Antimicrobial and anti-Fungal Agents. J. Mol. Struct. 2020, 1220, 128705. DOI: https://doi.org/10.1016/j.molstruc.2020.128705.
- Rezki, N.; Al-Yahyawi, A. M.; Bardaweel, S. K.; Al-Blewi, F. F.; Aouad, M. R. Synthesis of Novel 2,5-Disubstituted-1,3,4-Thiadiazoles Clubbed 1,2,4-Triazole, 1,3,4-Thiadiazole, 1,3,4-Oxadiazole and/or Schiff Base as Potential Antimicrobial and Antiproliferative Agents. Molecules 2015, 20, 16048–16067. DOI: https://doi.org/10.3390/molecules200916048.
- Rohand, T.; Ramli, Y.; Baruah, M.; Budka, J.; Das, A. M. Synthesis, Structure Elucidation and Antimicrobial Properties of New Bis-1, 3, 4-Oxadiazole Derivatives. Pharm. Chem. J. 2019, 53, 150–154. DOI: https://doi.org/10.1007/s11094-019-01969-2.
- Togashi, N.; Shiraishi, A.; Nishizaka, M.; Matsuoka, K.; Endo, K.; Hamashima, H.; Inoue, Y. Antibacterial Activity of Long-Chain Fatty Alcohols against Staphylococcus aureus. Molecules 2007, 12, 139–148. DOI: https://doi.org/10.3390/12020139.
- Daina, A.; Michielin, O.; Zoete, V. A. SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep. 2017, 7, 42717. DOI: https://doi.org/10.1038/srep42717.
- Arnott, J. A.; Planey, S. L. The Influence of Lipophilicity in Drug Discovery and Design. Expert Opin. Drug Discovery 2012, 7, 863–875. DOI: https://doi.org/10.1517/17460441.2012.714363.
- Lipinski, C. A. Lead-and Drug-like Compounds: The Rule-of-Five Revolution. Drug Discovery Today: Technol. 2004, 1, 337–341. DOI: https://doi.org/10.1016/j.ddtec.2004.11.007.
- Gad, E. M.; Nafie, M. S.; Eltamany, E. H.; Hammad, M. S. A. G.; Barakat, A.; Boraei, A. T. A. Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetrahydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, in Vitro, and in Vivo Activity Evaluation. Molecules 2020, 25, 2523. DOI: https://doi.org/10.3390/molecules25112523.
- Elsherif, M. A.; Hassan, A. S.; Moustafa, G. O.; Awad, H. M.; Morsy, N. M. Antimicrobial Evaluation and Molecular Properties Prediction of Pyrazolines Incorporating Benzofuran and Pyrazole Moieties. J. Appl. Pharm. Sci. 2020, 10, 37–43. DOI: https://doi.org/10.7324/JAPS.2020.102006.
- Ghannay, S.; Bakari, S.; Msaddek, M.; Vidal, S.; Kadri, A.; Aouadi, K. Design, Synthesis, Molecular Properties and in Vitro Antioxidant and Antibacterial Potential of Novel Enantiopure Isoxazolidine Derivatives. Arabian J. Chem. 2020, 13, 2121–2131. DOI: https://doi.org/10.1016/j.arabjc.2018.03.013.
- Collin, F.; Karkare, S.; Maxwell, A. Exploiting Bacterial DNA Gyrase as a Drug Target: Current State and Perspectives. Appl. Microbiol. Biotechnol. 2011, 92, 479–497. DOI: https://doi.org/10.1007/s00253-011-3557-z.
- Khan, T.; Sankhe, K.; Suvarna, V.; Sherje, A.; Patel, K.; Dravyakar, B. DNA Gyrase Inhibitors: Progress and Synthesis of Potent Compounds as Antibacterial Agents. Biomed. Pharmacother. 2018, 103, 923–938. DOI: https://doi.org/10.1016/j.biopha.2018.04.021.
- Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J. Comput. Chem. 2009, 30, 2785–2791. DOI: https://doi.org/10.1002/jcc.21256.